Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
14.48
+0.77 (5.62%)
At close: May 20, 2026, 4:00 PM EDT
14.55
+0.07 (0.48%)
After-hours: May 20, 2026, 4:33 PM EDT
TNXP Market Cap
TNXP has a market cap or net worth of $230.82 million as of May 20, 2026. Its market cap has increased by 83.20% in one year.
Market Cap
230.82M
Enterprise Value
46.80M
1-Year Change
83.20%
Ranking
Category
Stock Price
$14.48
Market Cap Chart
Since July 16, 2019, TNXP's market cap has increased from $7.29M to $230.82M, an increase of 3,064.70%. That is a compound annual growth rate of 65.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 218.55M | 12.91% |
| Dec 31, 2025 | 193.56M | 214.02% |
| Dec 31, 2024 | 61.64M | 160.94% |
| Dec 29, 2023 | 23.62M | 5.35% |
| Dec 30, 2022 | 22.42M | -87.36% |
| Dec 31, 2021 | 177.42M | 37.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 16, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MacroGenics | 270.13M |
| Anavex Life Sciences | 269.67M |
| Compugen | 260.02M |
| SAB Biotherapeutics | 260.02M |
| Editas Medicine | 256.51M |
| Minerva Neurosciences | 242.73M |
| Coherus Oncology | 242.17M |
| Alector | 239.81M |